Showing 1 - 11 results of 11 for search 'Marion de Jong', query time: 0.06s Refine Results
  1. 1
    Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?

    Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome? by Simone U. Dalm, Marion de Jong

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research

    The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research by Eline A.M. Ruigrok, Wytske M. van Weerden, Julie Nonnekens, Marion de Jong

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands

    Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands by Panagiotis Kanellopoulos, Aikaterini Kaloudi, Marion de Jong, Eric P. Krenning, Berthold A. Nock, Theodosia Maina

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer

    Towards Complete Tumor Resection: Novel Dual-Modality Probes for Improved Image-Guided Surgery of GRPR-Expressing Prostate Cancer by Maryana Handula, Marjolein Verhoeven, Kuo-Ting Chen, Joost Haeck, Marion de Jong, Simone U. Dalm, Yann Seimbille

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors

    Synthesis and Evaluation of Two Long-Acting SSTR2 Antagonists for Radionuclide Therapy of Neuroendocrine Tumors by Sofia Koustoulidou, Maryana Handula, Corrina de Ridder, Debra Stuurman, Savanne Beekman, Marion de Jong, Julie Nonnekens, Yann Seimbille

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [<sup>99m</sup>Tc]Tc-DB4 and [<sup>111</sup>In]In-SG4 in Mice Treated with Entresto

    One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [<sup>99m</sup>Tc]Tc-DB4 and [<sup>111</sup>In]In-SG4 in Mice Treated with Entresto by Panagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota, George Loudos, Marion de Jong, Eric P. Krenning, Berthold A. Nock, Theodosia Maina

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Localization of <sup>99m</sup>Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses

    Localization of <sup>99m</sup>Tc-GRP Analogs in GRPR-Expressing Tumors: Effects of Peptide Length and Neprilysin Inhibition on Biological Responses by Aikaterini Kaloudi, Emmanouil Lymperis, Panagiotis Kanellopoulos, Beatrice Waser, Marion de Jong, Eric P. Krenning, Jean Claude Reubi, Berthold A. Nock, Theodosia Maina

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Generation of fluorescently labeled tracers - which features influence the translational potential?

    Generation of fluorescently labeled tracers - which features influence the translational potential? by Fijs W. B. van Leeuwen, Bart Cornelissen, Federico Caobelli, Laura Evangelista, Latifa Rbah-Vidal, Silvana Del Vecchio, Catarina Xavier, Jacques Barbet, Marion de Jong

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy

    Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy by Ho Sze Chan, Erik de Blois, Mark W. Konijnenberg, Alfred Morgenstern, Frank Bruchertseifer, Jeffrey P. Norenberg, Fred J. Verzijlbergen, Marion de Jong, Wouter A. P. Breeman

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    [<sup>212</sup>Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors

    [<sup>212</sup>Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors by Dylan Chapeau, Sofia Koustoulidou, Maryana Handula, Savanne Beekman, Corrina de Ridder, Debra Stuurman, Erik de Blois, Yulia Buchatskaya, Karlijn van der Schilden, Marion de Jong, Mark W. Konijnenberg, Yann Seimbille

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo

    The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo by Maria J. Klomp, Leo J. Hofland, Lilian van den Brink, Peter M. van Koetsveld, Fadime Dogan, Corrina M. A. de Ridder, Debra C. Stuurman, Marian C. Clahsen-van Groningen, Marion de Jong, Simone U. Dalm

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: